1. Home
  2. NTRB

as of 08-11-2026 9:30am EST

$3.14
$0.04
-1.26%
Stocks Health Care Industrial Specialties Nasdaq

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Founded: 2016 Country:
United States
United States
Employees: N/A City: ORLANDO
Market Cap: 36.0M IPO Year: 2019
Target Price: N/A AVG Volume (30 days): 8.1K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.10 EPS Growth: -160.61
52 Week Low/High: $2.80 - $8.63 Next Earning Date: 05-29-2026
Revenue: $2,036,651 Revenue Growth: -4.81%
Revenue Growth (this year): 30.17% Revenue Growth (next year): 3394.36%
P/E Ratio: -31.80 Index: N/A
Free Cash Flow: -5139954.0 FCF Growth: N/A

Share on Social Networks: